NKTR Earnings

Quarterly EPS
$-2.66
Q3 2024
$0.18
Q4 2024
$-3.62
Q1 2025
$-2.95
Q2 2025
$-1.87
Q3 2025
$-1.77
Q4 2025
$-1.82
Q1 2026
$-1.23
Q2 2026
Latest Revenue10.1M
Latest Net Income-40622000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.2310.1M-40622000-9.3%+58.3%
Q1 2026-$1.8210.9M-44904000+3.8%+49.7%
Q4 2025-$1.7721.8M-36079000-25.3%-1,083.3%
Q3 2025-$1.8711.8M-35522000-51.1%+29.7%
Q2 2025-$2.9511.2M-41593000-52.4%+21.5%
Q1 2025-$3.6210.5M-50882000-51.7%-27.0%
Q4 2024$0.1829.2M7.3M+22.1%+105.5%
Q3 2024-$2.6624.1M-37057000-0.1%+26.1%
Q2 2024-$3.7623.5M-52363000
Q1 2024-$2.8521.6M-36802000
Q4 2023-$3.3023.9M-42079000
Q3 2023-$3.6024.1M-45837000
Nektar Therapeutics (NKTR) — Earnings